Cannell & Spears’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Cannell & Spears's MDT Position: Q2 2025 in Review
Cannell & Spears sold out of Medtronic (MDT) in Q2 2025, closing a stake of 15,851 shares — an estimated $1.42M sold.
Cannell & Spears first reported a position in MDT in Q3 2013 and held it in 17 quarters. The position peaked at $2.2M in Q1 2024. 2,145 funds tracked by Wall St. Rank hold MDT as of Q2 2025.
- Cannell & Spears reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
- Cannell & Spears sold 15,851 Medtronic shares in Q2 2025, an estimated $1.42M.
- Cannell & Spears first reported a position in Medtronic in Q3 2013 and held it in 17 quarters.
- Cannell & Spears's Medtronic position peaked at $2.2M in Q1 2024.
- 2,145 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.
Based on Cannell & Spears's 13F filing for Q2 2025, filed 14 Aug 2025.